WZ4002 (WZ-4002)是突变型EGFR (EGFR-T790M)的不可逆抑制剂，IC₅₀值为8 nM，结合EGFR激酶的活性构象，与Cys 797形成共价键，可用于治疗因EGFR突变引起的肺腺癌。

参考文献

1. Zhou W, et al. Novel mutant-selective EGFR kinase inhibitors against EGFR T790M.Nature. 2009 Dec 24;462(7276):1070-4.
2. Sakuma Y, et al. WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors. Lab Invest. 2012 Mar;92(3):371-83.

冰袋运输。粉末直接保存于-20℃，有效期3年。建议分装后-20℃干燥保存，避免反复冻融。